User profiles for "author:R Moots"

Robert Moots

Aintree University Hospital, Liverpool
Verified email at liv.ac.uk
Cited by 18269

Neutrophil function in inflammation and inflammatory diseases

HL Wright, RJ Moots, RC Bucknall… - Rheumatology, 2010 - academic.oup.com
In inflammatory conditions such as RA, the neutrophil has tended to be dismissed as a short-
lived, terminally differentiated, irrelevant bystander cell. However, this is clearly not the case …

The multifactorial role of neutrophils in rheumatoid arthritis

HL Wright, RJ Moots, SW Edwards - Nature Reviews Rheumatology, 2014 - nature.com
Of all cells implicated in the pathology of rheumatoid arthritis (RA), neutrophils possess the
greatest cytotoxic potential, owing to their ability to release degradative enzymes and …

Dopamine receptor expression on human T-and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study

F McKenna, PJ McLaughlin, BJ Lewis… - Journal of …, 2002 - Elsevier
This study documents expression of dopamine (DA) receptors on leukocyte subpopulations
using flow cytometric techniques to identify dopamine receptors with subtype-specific …

Birmingham vasculitis activity score (BVAS) Dim system necrotizinig vasculitis

RA Luqmani, PA Bacon, RJ Moots… - … Journal of Medicine, 1994 - academic.oup.com
The continuing morbidity of patients with vasculitis despite the improved prognosis with
aggressive therapy, underlines the need for accurate disease assessment We have devised …

2018 update of the EULAR recommendations for the management of Behçet's syndrome

…, A Gul, I Kötter, P Leccese, A Mahr, R Moots… - Annals of the …, 2018 - ard.bmj.com
Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a …

R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots… - The Lancet, 2017 - thelancet.com
Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the …

The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis

G Fossati, DA Moulding, DG Spiller… - The Journal of …, 2003 - journals.aai.org
It is commonly assumed that human neutrophils possess few, if any, functional mitochondria
and that they do not depend on these organelles for cell function. We have used the …

Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA

D Hutchinson, L Shepstone, R Moots, JT Lear… - Annals of the …, 2001 - ard.bmj.com
OBJECTIVES To investigate the potential relation between cumulative exposure to cigarette
smoking in patients with or without rheumatoid arthritis (RA) and a positive family history of …

[HTML][HTML] Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven …

…, B Dasgupta, A Cauli, P Reynolds, JD Cañete, R Moots… - The Lancet, 2021 - thelancet.com
Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …

[HTML][HTML] The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis

TC Barnes, ME Anderson, RJ Moots - International journal of …, 2011 - hindawi.com
Interleukin-6 is currently attracting significant interest as a potential therapeutic target in
systemic sclerosis (SSc). In this paper, the biology of interleukin-6 is reviewed, and the …